Celera Registers Shares with Nasdaq on Eve of Split with ABI | GenomeWeb
NEW YORK (GenomeWeb News) – Celera, which is scheduled to officially split tomorrow from parent firm Applera and sister company Applied Biosystems, has registered to have its shares float on the Nasdaq Stock Market.
 
The firm’s shares currently trade as a tracking stock of Applera on the New York Stock Exchange. Its stock will be delisted from the New York Stock Exchange when the split is finalized.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.